1. Home
  2. AMST vs ENSC Comparison

AMST vs ENSC Comparison

Compare AMST & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMST
  • ENSC
  • Stock Information
  • Founded
  • AMST 2017
  • ENSC 2003
  • Country
  • AMST United States
  • ENSC United States
  • Employees
  • AMST N/A
  • ENSC N/A
  • Industry
  • AMST Computer Software: Prepackaged Software
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMST Technology
  • ENSC Health Care
  • Exchange
  • AMST Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • AMST 7.4M
  • ENSC 7.9M
  • IPO Year
  • AMST 2020
  • ENSC N/A
  • Fundamental
  • Price
  • AMST $2.90
  • ENSC $6.00
  • Analyst Decision
  • AMST
  • ENSC
  • Analyst Count
  • AMST 0
  • ENSC 0
  • Target Price
  • AMST N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • AMST 38.8K
  • ENSC 52.1K
  • Earning Date
  • AMST 02-10-2025
  • ENSC 03-14-2025
  • Dividend Yield
  • AMST N/A
  • ENSC N/A
  • EPS Growth
  • AMST N/A
  • ENSC N/A
  • EPS
  • AMST N/A
  • ENSC N/A
  • Revenue
  • AMST $86,115.00
  • ENSC $4,421,404.00
  • Revenue This Year
  • AMST N/A
  • ENSC $89.78
  • Revenue Next Year
  • AMST N/A
  • ENSC N/A
  • P/E Ratio
  • AMST N/A
  • ENSC N/A
  • Revenue Growth
  • AMST N/A
  • ENSC 40.41
  • 52 Week Low
  • AMST $1.85
  • ENSC $2.12
  • 52 Week High
  • AMST $6.27
  • ENSC $14.85
  • Technical
  • Relative Strength Index (RSI)
  • AMST 36.98
  • ENSC 41.25
  • Support Level
  • AMST $3.16
  • ENSC $5.34
  • Resistance Level
  • AMST $3.40
  • ENSC $6.19
  • Average True Range (ATR)
  • AMST 0.22
  • ENSC 0.44
  • MACD
  • AMST -0.02
  • ENSC -0.04
  • Stochastic Oscillator
  • AMST 10.64
  • ENSC 32.79

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: